The Status Quo of Pharmacogenomics of Tyrosine Kinase Inhibitors in Precision Oncology: A Bibliometric Analysis of the Literature

• Autori principali: Abdallah Alzoubi (Autore), Hassan Shirazi (Autore), Ahmad Alrawashdeh (Autore), Arwa M. AL-Dekah (Autore), Nadia Ibraheem (Autore), Khalid A. Kheirallah (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2024-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Precision oncology and pharmacogenomics (PGx) intersect in their overarching goal to institute the right treatment for the right patient. However, the translation of these innovations into clinical practice is still lagging behind. Therefore, this study aimed to analyze the current state of research...